Trial of Levofloxacin as Prophylaxis After Allogeneic Stem Cell Transplantation (SCT)
Status:
Unknown status
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy of levofloxacin to prevent bacterial
infections in the postneutropenic period in patients who have undergone allogeneic stem cell
transplantation (SCT).